Is Bionik Laboratories Corp. (BNKL) a Buy, Sell, or Hold?
OTC : BNKL
Bionik Laboratories Corp.
$0.0001 USD
$0 (0.0%)
- Volume
- 578
- Average Volume
- 528
- Market Capitalization
- $1.25K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.20
Company Overview
OTC
Richard Paul Russo Jr.
Medical - Care Facilities
Healthcare
BNKL
12
US
USD
Liquidity Metrics
-1.47
1.20
0.75
0.19
0.00
Sales & Valuation
$1.81M
0.00
0.00
0.00
-0.49
Profitability
-$0.72
-$4.95M
-273.99%
-273.99%
-768.84%
-147.11%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-45.83
2/9
$468.38K
$3.36M
$5M
-$4.84M
Key Metrics (TTM)
$1.99M
1.10
-0.42
1.20
-768.84%
-448.84%
-716434.64%
-271419.39%
305 days
Company Executives
| Name | Title |
|---|---|
| Richard Paul Russo Jr. | Chief Executive Officer, President & Director |
| John Smathers | Director of Operations |
| Michal Prywata | Co-Founder & Director |
| Daniel Gonsalves | Executive Vice President & Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Bionik Laboratories Corp. (OTC:BNKL) Stock
Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMoti ... on Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.
Frequently Asked Questions
-
What is the current Bionik Laboratories Corp. (BNKL) stock price?
-
Bionik Laboratories Corp.(OTC:BNKL) stock price is $0.0001 in the last trading session. During the trading session, BNKL stock reached the peak price of $0.0001 while $0.0001 was the lowest point it dropped to. The percentage change in BNKL stock occurred in the recent session was 0.0% while the dollar amount for the price change in BNKL stock was $0.
-
BNKL's industry and sector of operation?
-
The OTC listed BNKL is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of BNKL?
-
Richard Paul Russo Jr. | Chief Executive Officer, President & Director
John Smathers | Director of Operations
Michal Prywata | Co-Founder & Director
Daniel Gonsalves | Executive Vice President & Chief Financial Officer
| -
How many employees does BNKL have?
-
Number of BNKL employees currently stands at 12. BNKL operates from 80 Coolidge Hill Road, Watertown, MA 02472, US.
-
Link for BNKL official website?
-
Official Website of BNKL is: https://www.bioniklabs.com
-
How do I contact BNKL?
-
BNKL could be contacted at phone #617 926 4800 and can also be accessed through its website. BNKL operates from 80 Coolidge Hill Road, Watertown, MA 02472, US.
-
How many shares of BNKL are traded daily?
-
The average number of BNKL shares traded daily for last 3 months was 528.
-
What is the market cap of BNKL currently?
-
The market value of BNKL currently stands at $1.25K with its latest stock price at $0.0001